Nicox Provides Second Quarter 2023 Financial and Business

Press ReleaseNicox Provides Second Quarter 2023 Financial and Business Highlights Net revenue1 of €0.9 million for the second quarter of 2023 Cash...

Related Keywords

London ,City Of ,United Kingdom ,New York ,United States ,Valbonne ,Provence Alpes Côd Azur ,France ,Paris ,France General ,China ,Mexico ,French ,Chinese ,Kepler Cheuvreux ,Arsene Guekam ,Gavin Spencer ,Yi Chen ,Pooya Hemami ,Mont Blanc ,Eric Yoo ,Sophia Antipolis ,Andreas Segerros ,Hc Wainwright Co ,Garnier Co ,Santen Pharmaceutical Co Ltd ,World Glaucoma Congress ,Eyevance Pharmaceuticals ,Bloomberg ,Edison Investment Research ,Head Of Corporate Development ,Nicox Group ,Provides Second Quarter ,Euronext Paris ,Denali Phase ,Chief Executive Officer ,Ocumension Therapeutics ,Priority Review Status ,Drug Application ,Kreos Capital ,French State ,Southeast Asian ,Euronext Growth Paris ,Investment Research ,Vice President ,Chief Business ,Corporate Development ,Rapport Annuel ,Black Scholes ,Paris Stock Exchange Cox ,Nicox ,